RIA
BIB icon

RPG Investment Advisory’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

RPG Investment Advisory’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,980
Closed -$170K – 294
2018
Q2 		$170K Hold
2,980
– – 0.04% 104
2018
Q1 		$164K Sell
2,980
-78
-3% -$4.67K 0.04% 117
2017
Q4 		$171K Sell
3,058
-400
-12% -$22.6K 0.04% 111
2017
Q3 		$212K Sell
3,458
-88,272
-96% -$5.02M 0.05% 112
2017
Q2 		$4.9M Buy
91,730
+55
+0.1% +$2.68K 1.34% 24
2017
Q1 		$4.42M Sell
91,675
-13,423
-13% -$624K 1.29% 28
2016
Q4 		$4.19M Sell
105,098
-5,217
-5% -$223K 1.42% 24
2016
Q3 		$5.34M Sell
110,315
-17,891
-14% -$850K 1.67% 16
2016
Q2 		$4.97M Buy
128,206
+44,913
+54% +$1.94M 1.33% 24
2016
Q1 		$3.4M Buy
83,293
+3,910
+5% +$173K 1.32% 31
2015
Q4 		$5.67M Buy
+79,383
New +$5.3M 2.12% 11

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 25.49% 1-Year Est. Return
BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RPG Investment Advisory's BIB Position: Q3 2018 in Review

RPG Investment Advisory sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2018, closing a stake of 2,980 shares — an estimated $170K sold.

RPG Investment Advisory first reported a position in BIB in Q4 2015 and held it in 11 quarters. The position peaked at $5.67M in Q4 2015. 41 funds tracked by Wall St. Rank hold BIB as of Q3 2018.

  • RPG Investment Advisory reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2018 after selling out during the quarter.
  • RPG Investment Advisory sold 2,980 ProShares Ultra NASDAQ Biotechnology shares in Q3 2018, an estimated $170K.
  • RPG Investment Advisory first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2015 and held it in 11 quarters.
  • RPG Investment Advisory's ProShares Ultra NASDAQ Biotechnology position peaked at $5.67M in Q4 2015.
  • 41 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2018.

Based on RPG Investment Advisory's 13F filing for Q3 2018, filed 5 Nov 2018.